Windtree Therapeutics Overview
Windtree Therapeutics (WINT) has a ROE of -506155.56%, below the Healthcare sector average of 29.33%.
Get informed when a big investor buys or sells
+ Follow-506155.56%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Windtree Therapeutics (WINT) currently reports a ROE of -506155.56%. That is below the Healthcare sector average of 29.33%. Use the charts on this page to explore Windtree Therapeutics's ROE history and peer comparisons.
Windtree Therapeutics's ROE of -506155.56% is lower than the Healthcare sector average of 29.33%. That is roughly 1725755.2% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but Windtree Therapeutics's current -506155.56% should be judged against Healthcare norms (sector average: 29.33%) and against WINT's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of -506155.56%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 29.33%. From there, open related valuation or income-statement pages for Windtree Therapeutics, and consider following WINT for alerts when major investors trade the stock.
Windtree Therapeutics is classified in the Healthcare sector. On ROE, it currently shows -506155.56% versus a sector average near 29.33%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing WINT with unrelated industries.
